Health & Medicine Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy.....

1. ASCO: OPTiM: A Randomized Phase 3 Trial Of Talimogene Laherparepvec (T-VEC) vs Subcutaneous Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) For The Treatment…